Investigators reported two silica column–based protocols to purify single-stranded DNA (ssDNA) from filamentous phages. The methods use two chaotropic salts—guanidine hydrochloride and potassium iodide—to promote ssDNA binding to silica. The work targeted the model phages M13KO7 (Escherichia coli) and Pf4 (Pseudomonas aeruginosa). The preprint emphasized that existing commercial kits, developed for double-stranded DNA, deliver variable ssDNA yields and are proprietary, limiting troubleshooting and customization; the new protocols were designed to be fully tunable for different phages.
Data indicated recoveries between 60% and 100% for the two protocols when applied to M13KO7 and Pf4. Investigators compared those yields directly to the Monarch Spin gDNA Extraction and DNeasy Blood and Tissue kits and found equal or higher recovery with the chaotrope/silica methods. Purity metrics—A260/280 and A260/230 ratios—were similar between the new protocols and the commercial kits. DNA integrity was preserved on agarose gels, and PCR assays detected no host genomic DNA contamination in the purified ssDNA preparations.
The study team observed that recovery depended critically on the presence of the chaotropic salts and on ethanol in the workflow. Lowering pH did not increase recovery, a result the authors interpreted in mechanistic terms: data indicated that water exclusion—leading to hydrophobic interactions and hydrogen bonding between nucleic acid and silica—likely dominates over electrostatic repulsion in this binding regime. The abstract did not present stepwise reagent concentrations or full procedural parameters in the summary, so readers will need to consult the full preprint or supplementary material for detailed protocol steps and exact buffer formulations.
Investigators reported measurable differences in recovery across phage types, implying that no single fixed protocol will be optimal for all filamentous phages. The authors noted that the customizable nature of their methods should allow laboratories to tune chaotrope identity, ethanol content, and wash/elution conditions to maximize recovery for a given phage. The preprint framed this flexibility as an advantage over proprietary kits, which conceal solution compositions and limit troubleshooting. The dataset presented in the abstract suggests that labs planning to adopt these procedures should expect to perform modest optimization when working with novel or less-characterized phages.
The authors compared the virion ssDNA genomes to the double-stranded replicative form (RF) DNA for both phages. That comparison revealed genome variants in each phage. One specific observation was a shorter M13KO7 form missing the kanamycin resistance–p15A insert. The study team used these findings to argue for routine analysis of both RF and virion ssDNA when characterizing filamentous phage biology and when engineering phage genomes, since differences can arise between the packaged single-stranded genome and intracellular double-stranded forms.
This report appears as a bioRxiv preprint and has not been peer reviewed. The abstract supplied the core findings summarized above but did not list explicit reagent volumes, concentrations, incubation times, or step-by-step procedural details in that section; readers should consult the full manuscript and supplementary materials for the complete protocols and exact parameters. The authors documented phage-dependent variability in recovery, which the field will need to address through empirical optimization for additional filamentous phages. Practical next steps noted in the preprint include implementing the protocols in routine phage workflows and applying the customizable conditions to expand the methods to other phage species.
The preprint disclosed no competing interests. The funders and author affiliations are listed in the manuscript metadata. Practitioners seeking to adopt these methods should refer to the full text for protocol specifics and consider internal validation—particularly yield, purity metrics, and absence of host DNA—before integrating the methods into production or diagnostic pipelines.